BIOAGE LABS INC (BIOA) Forecast, Price Target & Analyst Ratings

NASDAQ:BIOA • US09077V1008

Current stock price

16.15 USD
-0.1 (-0.62%)
At close:
16 USD
-0.15 (-0.93%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOAGE LABS INC (BIOA).

Forecast Snapshot

Consensus Price Target

Price Target
$44.27
+ 174.11% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q4 / 2025
EPS Estimate
-$0.75
Revenue Estimate
1.426M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$44.27
Upside
+ 174.11%
From current price of $16.15 to mean target of $44.27, Based on 12 analyst forecasts
Low
$9.09
Median
$53.04
High
$76.65

Price Target Revisions

1 Month
44.67%
3 Months
261.67%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for BIOA. The average price target is 44.27 USD. This implies a price increase of 174.11% is expected in the next year compared to the current price of 16.15.
The average price target has been revised upward by 261.67% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BIOA Current Analyst RatingBIOA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

BIOA Historical Analyst RatingsBIOA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
BIOA was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BIOA.
In the previous month the buy percentage consensus was at a similar level.
BIOA was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-27NeedhamInitiate Buy
2026-03-10CitigroupMaintains Buy -> Buy
2026-02-25OppenheimerInitiate Outperform
2026-02-18JefferiesUpgrade Hold -> Buy
2026-01-27Piper SandlerInitiate Overweight
2025-12-08Morgan StanleyUpgrade Underweight -> Equal-Weight
2025-10-29CitigroupMaintains Buy -> Buy
2025-10-22CitigroupUpgrade Neutral -> Buy
2025-03-24CitigroupMaintains Neutral -> Neutral
2025-02-28William BlairInitiate Market Perform
2024-12-09CitigroupDowngrade Buy -> Neutral
2024-12-09JefferiesDowngrade Buy -> Hold
2024-10-21Morgan StanleyInitiate Overweight
2024-10-21CitigroupInitiate Buy
2024-10-21JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q4 / 2025
EPS Estimate
-$0.75
Revenue Estimate
1.426M
Revenue Q2Q
N/A
EPS Q2Q
61.74%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
22.61%
Revenue (3 Months)
-1.93%
EPS (1 Month)
2.42%
EPS (3 Months)
4.37%

Next Earnings Summary

BIOA is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.75 USD and the consensus revenue estimate is 1.43M USD.
The next earnings revenue estimate has been revised downward by 1.93% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BIOA revenue by date.BIOA revenue by date.
N/AN/A
898.47%		N/A
-99.04%		N/A
-100.00%		N/AN/A
33.27%		N/A
25.04%		N/A
1,822.16%		N/A
396.31%
EBITDA
YoY % growth
BIOA ebitda by date.BIOA ebitda by date.
-39.84M-48.238M
-21.08%		-78.027M
-61.75%		N/A
-15.77%		N/A
-25.88%		N/A
6.18%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
BIOA ebit by date.BIOA ebit by date.
-39.969M-48.4M
-21.09%		-78.194M
-61.56%		N/A
-16.74%		N/A
50.94%		N/A
-35.05%		N/A
-160.20%		N/A
-14.59%		N/A
-19.72%		N/A
31.61%		N/A
16.12%		N/A
158.41%
Operating Margin
BIOA operating margin by date.BIOA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BIOA eps by date.BIOA eps by date.
N/AN/AN/AN/A
71.91%		N/A
-19.31%		N/A
0.43%		N/AN/AN/A
-20.84%		N/A
-18.74%		N/A
11.17%		N/A
96.22%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		-0.75
61.74%		-0.68
-88.28%		-0.68
-13.45%		-0.69
-23.80%		-0.77
-2.41%		-0.72
-6.85%		-0.74
-8.64%		-0.77
-10.35%		-0.78
-0.44%		-0.72-0.74
-0.69%		-0.79
-2.67%
Revenue
Q2Q % growth		1.426M918K
-36.73%		918K
-61.94%		918K
-55.31%		242.25M
16,888.08%
-100.00%
-100.00%
-100.00%
-100.00%		N/AN/AN/A
EBITDA
Q2Q % growth		-24.173M
4.05%		-23.471M
-43.04%		-25.7M
-4.15%		-25.598M
-11.31%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-25.646M
-1.12%		-25.603M
-55.68%		-27.146M
-9.59%		-27.523M
-18.94%		211.96M
926.50%		-30.216M
-18.02%		31.426M
215.77%		32.694M
218.79%		34.021M
-83.95%		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BIOA Yearly Revenue VS EstimatesBIOA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2029 2030 2031 2032 2033 50M 100M 150M
BIOA Yearly EPS VS EstimatesBIOA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2029 2030 2031 2032 2033 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
18.55%
EPS Next 5 Year
8.24%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-10.64%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BIOAGE LABS INC / BIOA Forecast FAQ

What is the average price target for BIOAGE LABS INC (BIOA) stock?

12 analysts have analysed BIOA and the average price target is 44.27 USD. This implies a price increase of 174.11% is expected in the next year compared to the current price of 16.15.

Can you provide the upcoming earnings date for BIOAGE LABS INC?

BIOAGE LABS INC (BIOA) will report earnings on 2026-05-04.

Can you provide the consensus estimates for BIOAGE LABS INC next earnings?

The consensus EPS estimate for the next earnings of BIOAGE LABS INC (BIOA) is -0.75 USD and the consensus revenue estimate is 1.43M USD.

What is the number of analysts for BIOA stock?

The number of analysts covering BIOAGE LABS INC (BIOA) is 12.